LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
28.03
+0.76 (2.79%)
May 20, 2026, 4:00 PM EDT - Market closed
LB Pharmaceuticals Market Cap
LB Pharmaceuticals has a market cap or net worth of $803.81 million as of May 20, 2026.
Market Cap
803.81M
Enterprise Value
441.64M
1-Year Change
n/a
Ranking
Category
Stock Price
$28.03
Market Cap Chart
Since the IPO on September 11, 2025, LB Pharmaceuticals's market cap has increased from $301.50M to $803.81M, an increase of 166.60%. That is a compound annual growth rate of 316.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 803.81M | 42.73% |
| Dec 31, 2025 | 563.16M | 86.78% |
| Sep 11, 2025 | 301.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xencor | 839.28M |
| Seaport Therapeutics | 836.78M |
| Annexon | 825.77M |
| Aura Biosciences | 823.94M |
| CytomX Therapeutics | 809.85M |
| Geron | 808.32M |
| Evommune | 802.49M |
| Odyssey Therapeutics | 800.31M |